Chris Lockhart, PhDResearch Assistant ProfessorGeorge Mason University

Research Interests

Biological Systems

Our lab investigates the structural ensembles and interactions of critical biomolecules. A major focus of our work is the study of Alzheimer’s disease Aβ peptides and antimicrobial peptides bound to lipid bilayers, exploring the fundamental mechanisms that drive their function and pathology.

Selected Recent Publications:

Computational Methodology

We develop and apply advanced enhanced sampling techniques to overcome the timescale limitations of standard molecular dynamics. Our expertise centers on replica-exchange molecular dynamics (REMD) simulations, including variants such as replica-exchange with solute tempering (REST). We also rigorously investigate biomolecular force field dependence through exhaustive simulations.

Selected Recent Publications:

Drug Discovery

We leverage computational biophysics to accelerate the discovery and optimization of novel therapeutics. Our methodologies include free energy perturbation (FEP) techniques, ensemble-based drug design, MM-GBSA, molecular docking, and the rigorous force field parameterization of ligands to understand their impact on protein structure.

Selected Recent Publications:

Artificial Intelligence

We apply modern artificial intelligence and machine learning algorithms to uncover hidden patterns within complex biological data. By integrating these predictive models with both massive biomolecular simulation datasets and clinical omics profiles, we bridge the gap between raw data and actionable insights into disease pathology and drug resistance.

Selected Recent Publications: